Kyu Yean Kim, Ho Cheol Kim, Tae Jung Kim, Hong Kwan Kim, Mi Hyung Moon, Kyongmin Sarah Beck, Yang Gun Suh, Chang Hoon Song, Jin Seok Ahn, Jeong Eun Lee, Jae Hyun Jeon, Chi Young Jung, Jeong Su Cho, Yoo Duk Choi, Seung Sik Hwang, Chang Min Choi, Seung Hun Jang, Jeong Uk Lim, Korean Association for Lung Cancer, Korea Central Cancer Registry
Cancer Res Treat. 2025;57(1):83-94. Published online July 10, 2024
Purpose Recent development in perioperative treatment of resectable non–small cell lung cancer (NSCLC) have changed the landscape of early lung cancer management. The ADAURA trial has demonstrated the efficacy of adjuvant osimertinib treatment in resectable NSCLC patients; however, studies are required to show which subgroup of patients are at a high risk of relapse and require adjuvant epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor treatment. This study evaluated risk factors for postoperative relapse among patients who underwent complete resection.
Materials and Methods Data were obtained from the Korean Association for Lung Cancer Registry (KALC-R), a database created using a retrospective sampling survey by the Korean Central Cancer Registry (KCCR) and the Lung Cancer Registration Committee.
Results A total of 3,176 patients who underwent curative resection was evaluated. The mean observation time was approximately 35.4 months. Among stage I to IIIA NSCLC patients, the EGFR-mutant subgroup included 867 patients, and 75.2%, 11.2%, and 11.8% were classified as stage I, stage II, and stage III, respectively. Within the EGFR-mutant subgroup, 44 (5.1%) and 121 (14.0%) patients showed early and late recurrence, respectively. Multivariate analysis on association with postoperative relapse among the EGFR-mutant subgroup showed that age, pathologic N and TNM stages, pleural invasion status, and surgery type were independent significant factors.
Conclusion Among the population that underwent complete resection for early NSCLC with EGFR mutation, patients with advanced stage, pleural invasion, or limited resection are more likely to show postoperative relapse.
Da Som Jeon, Ho Cheol Kim, Se Hee Kim, Tae-Jung Kim, Hong Kwan Kim, Mi Hyung Moon, Kyongmin Sarah Beck, Yang-Gun Suh, Changhoon Song, Jin Seok Ahn, Jeong Eun Lee, Jeong Uk Lim, Jae Hyun Jeon, Kyu-Won Jung, Chi Young Jung, Jeong Su Cho, Yoo-Duk Choi, Seung-Sik Hwang, Chang-Min Choi, Korean Association for Lung Cancer, Korea Central Cancer Registry
Cancer Res Treat. 2023;55(1):103-111. Published online June 20, 2022
Purpose This study aimed to provide the clinical characteristics, prognostic factors, and 5-year relative survival rates of lung cancer diagnosed in 2015.
Materials and Methods The demographic risk factors of lung cancer were calculated using the KALC-R (Korean Association of Lung Cancer Registry) cohort in 2015, with survival follow-up until December 31, 2020. The 5-year relative survival rates were estimated using Ederer II methods, and the general population data used the death rate adjusted for sex and age published by the Korea Statistical Information Service from 2015 to 2020.
Results We enrolled 2,657 patients with lung cancer who were diagnosed in South Korea in 2015. Of all patients, 2,098 (79.0%) were diagnosed with non–small cell lung cancer (NSCLC) and 345 (13.0%) were diagnosed with small cell lung cancer (SCLC), respectively. Old age, poor performance status, and advanced clinical stage were independent risk factors for both NSCLC and SCLC. In addition, the 5-year relative survival rate declined with advanced stage in both NSCLC (82%, 59%, 16%, 10% as the stage progressed) and SCLC (16%, 4% as the stage progressed). In patients with stage IV adenocarcinoma, the 5-year relative survival rate was higher in the presence of epidermal growth factor receptor (EGFR) mutation (19% vs. 11%) or anaplastic lymphoma kinase (ALK) translocation (38% vs. 11%).
Conclusion In this Korean nationwide survey, the 5-year relative survival rates of NSCLC were 82% at stage I, 59% at stage II, 16% at stage III, and 10% at stage IV, and the 5-year relative survival rates of SCLC were 16% in cases with limited disease, and 4% in cases with extensive disease.
Citations
Citations to this article as recorded by
Weight loss as a predictor of reduced survival in patients with lung cancer: a systematic review with meta-analysis Junfang Zhang, Xuan Tang, Wenbo Zhang, Ying Xu, Heng Zhang, Yu Fan International Journal of Obesity.2025; 49(1): 13. CrossRef
Preclinical safety and effectiveness of a long-acting somatostatin analogue [225Ac]Ac-EBTATE against small cell lung cancer and pancreatic neuroendocrine tumors Fabrice N. Njotu, Jessica Pougoue Ketchemen, Hanan Babeker, Nikita Henning, Anjong F. Tikum, Emmanuel Nwangele, Alissar Monzer, Nava Hassani, Brian D. Gray, Koon Y. Pak, Emina E. Torlakovic, Maruti Uppalapati, Humphrey Fonge European Journal of Nuclear Medicine and Molecular Imaging.2025; 52(4): 1305. CrossRef
Interactions and communications in lung tumour microenvironment: chemo/radiotherapy resistance mechanisms and therapeutic targets Yuan Feng, Ying Jiang, Lin Yang, Danni Lu, Ning Li, Qun Zhang, Haiyan Yang, Huiyuan Qin, Jiaxin Zhang, Xinyun Gou, Feng Jiang Journal of Drug Targeting.2025; 33(6): 817. CrossRef
The systematic analysis of genes related to butyrate metabolism suggests that CDKN3 could serve as a promising therapeutic target for lung adenocarcinoma treatment Yanchao Luan, Chao Liang, Qingsong Han, Xueqin Zhou, Na Yang, li Zhao BMC Cancer.2025;[Epub] CrossRef
Secretome and Proteome of Extracellular Vesicles Provide Protein Markers of Lung and Colorectal Cancer Natalia Soloveva, Svetlana Novikova, Tatiana Farafonova, Olga Tikhonova, Victor Zgoda International Journal of Molecular Sciences.2025; 26(3): 1016. CrossRef
Baseline 18F-FDG PET/CT parameters in predicting the efficacy of immunotherapy in non-small cell lung cancer Lu Zheng, Yanzhu Bian, Yujing Hu, Congna Tian, Xinchao Zhang, Shuheng Li, Xin Yang, Yanan Qin Frontiers in Medicine.2025;[Epub] CrossRef
Artificial intelligence-assisted point-of-care devices for lung cancer Xin Jie Keith Ng, Anis Salwa Mohd Khairuddin, Hai Chuan Liu, Thian Chee Loh, Jiunn Liang Tan, Sook Mei Khor, Bey Fen Leo Clinica Chimica Acta.2025; 570: 120191. CrossRef
Genetic Navigation: A Narrative Review of XRCC1 Polymorphism Impact on Platinum-Based Chemotherapy Outcomes in NSCLC Patients Lanny Permatasari, Nadiya Afifah, Maryam Ishmatullah, Ruri Intania, Eli Halimah, Melisa Barliana Cancer Management and Research.2025; Volume 17: 383. CrossRef
Multivariable model for predicting 5-year survival in patients with EGFR-mutated non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors: a retrospective study Qi-An Wang, I-Lin Tsai, Chien-Yu Lin, Po-Lan Su, Chien-Chung Lin, John Wen-Cheng Chang, Chen-Yang Huang, Yueh-Fu Fang, Ching-Fu Chang, Chih-Hsi Scott Kuo, Ping-Chih Hsu, Cheng-Ta Yang, Chiao-En Wu Therapeutic Advances in Medical Oncology.2025;[Epub] CrossRef
Ex-Vivo Drug-Sensitivity Testing to Predict Clinical Response in Non-Small Cell Lung Cancer and Pleural Mesothelioma: A Systematic Review and Narrative Synthesis Jenny Zipprick, Enes Demir, Hanna Krynska, Sıla Köprülüoğlu, Katharina Strauß, Marcus Skribek, Rita Hutyra-Gram Ötvös, Annica K. B. Gad, Katalin Dobra Cancers.2025; 17(6): 986. CrossRef
Defining long-term survivors in metastatic lung cancer: insights from a Delphi study in Spain Enric Carcereny, Manuel Domine, Ana Laura Ortega Granados Frontiers in Oncology.2025;[Epub] CrossRef
Genomics and the early diagnosis of lung cancer Francesco Pepe, Tancredi Didier Bazan Russo, Valerio Gristina, Andrea Gottardo, Giulia Busuito, Giuliana Iannì, Gianluca Russo, Claudia Scimone, Lucia Palumbo, Lorena Incorvaia, Giuseppe Badalamenti, Antonio Galvano, Viviana Bazan, Antonio Russo, Giancarl Personalized Medicine.2025; 22(3): 161. CrossRef
Single-cell transcriptomics and machine learning unveil ferroptosis features in tumor-associated macrophages: Prognostic model and therapeutic strategies for lung adenocarcinoma Ting Ji, Juanli Jiang, Xin Wang, Kai Yang, Shaojin Wang, Bin Pan Frontiers in Pharmacology.2025;[Epub] CrossRef
Senescence-associated secretory phenotype in lung cancer: remodeling the tumor microenvironment for metastasis and immune suppression Chen Chen, Ji Chen, Yanling Zhang, Qijun Zhang, Haixia Shi Frontiers in Oncology.2025;[Epub] CrossRef
A Systematic Review and Meta-Analysis of the Efficacy and Safety of Lazertinib as First-Line Treatment for EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Louis Fabio Jonathan Jusni, Eric Ricardo Yonatan, Nicolas Daniel Widjanarko, Rio Gusta Notario Besri Hematology/Oncology and Stem Cell Therapy.2025; 18(2): 48. CrossRef
The predictive value of ferroptosis marker SLC7A11 in the prognosis of advanced non-small cell lung cancer patients Shiqiang Wang, Xinlai Jin, Xuefei Yang, Zhidi Zhang Clinical Biochemistry.2025; 138: 110961. CrossRef
p53 aberrant expression is pervasive in pleomorphic carcinomas of the lung and a sensitive diagnostic adjunct for biopsy specimens Joshua Jing Xi Li, Chit Chow, Joanna Ka Man Ng, Ka Pang Chan, Molly Siu Ching Li, Ka-Fai To Diagnostic Pathology.2025;[Epub] CrossRef
Diagnostic performance of artificial intelligence models for pulmonary nodule classification: a multi-model evaluation Sarah K. Herber, Lukas Müller, Daniel Pinto dos Santos, Tobias Jorg, Fabio Souschek, Tobias Bäuerle, Sebastian Foersch, Christian Galata, Peter Mildenberger, Moritz C. Halfmann European Radiology.2025;[Epub] CrossRef
Small-Cell Lung Cancer Updates Yunan Nie, Anne C. Chiang Seminars in Respiratory and Critical Care Medicine.2025;[Epub] CrossRef
A shape complementarity strategy based on NCA029 enables potent HsClpP agonists for the treatment of small cell lung carcinoma Linjie Li, Baozhu Luo, Xudong Wang, Zhongyu Jian, Hong Liu, Bo Ren, Wenliang Qiao, Youfu Luo, Tao Yang European Journal of Medicinal Chemistry.2025; 299: 118008. CrossRef
CLDN4 regulates cell proliferation in small cell lung cancer cells via SAA1 inhibition Korehito Kashiwagi, Hanako Sato-Yazawa, Jun Ishii, Masami Iwamoto, Kakeru Kohno, Tadasuke Miyazawa, Tamotsu Kamimura, Shunsuke Miyata, Ruri Sugiyama, Hideki Chiba, Takuya Yazawa Biochemical and Biophysical Research Communications.2025; 785: 152710. CrossRef
Autophagy inhibition enhances sensitivity of alpelisib in PI3K–mutated non-small cell lung cancer Jinyoung Kim, Chandani Shrestha, Tae Woo Kim, Sang-Bin Lee, Gwangbin Lee, Dasom Jung, Min Hwang, Shinwon Kang, Hyung Soon Park, Hyunho Kim, Ho Jung An, Dongwoo Chae, Byoung Yong Shim, Jiyoon Kim Biomedicine & Pharmacotherapy.2025; 192: 118620. CrossRef
Lung Cancer Management: A Comprehensive Review with Special Focus on Natural Remedies and Bioactive Compounds Raj Shekhar, P. Muralidharan, Namrata Hallur, S. B. Puranik, Phatru Patel Journal of Natural Remedies.2025; : 1989. CrossRef
Ferroptosis and non-coding RNAs in lung cancer: exploring molecular mechanisms and diagnostic/therapeutic implications Hedong Xue, Melika Malek, Liangyu Li Cancer Cell International.2025;[Epub] CrossRef
Association of Pre‐ and Postdiagnosis Physical Activity, Promotion and Maintenance With Lung Cancer Survival: A Nationwide Cohort Study Yeon Wook Kim, Kyeong Im Kwak, A‐Reum Choi, Eung Joo Park, Brian J. Lee, Yeon Joo Lee, Choon‐Taek Lee Journal of Cachexia, Sarcopenia and Muscle.2025;[Epub] CrossRef
Directions of Immunotherapy for Non-Small-Cell Lung Cancer Treatment: Past, Present and Possible Future Gian Marco Leone, Grazia Scuderi, Paolo Fagone, Katia Mangano International Journal of Molecular Sciences.2025; 26(22): 11055. CrossRef
Radiogenomic insights from a Portuguese lung cancer cohort: Foundations for predictive modeling Inês Neves, Cláudia Freitas, Carolina Lemos, Hélder P. Oliveira, Venceslau Hespanhol, Manuela França, Tania Pereira Measurement and Evaluations in Cancer Care.2025; 3: 100025. CrossRef
Hyperthermic Intrathoracic Chemotherapy and Photodynamic Therapy: A Single-Institution Experience for Malignant Pleural Diseases Yu-An Zheng, Ke-Cheng Chen, Pei-Ming Huang, Mong-Wei Lin, Shuenn-Wen Kuo, Jang-Ming Lee Oncology.2025; : 1. CrossRef
Lung Cancer Outcomes in Vietnam: A 6-Year Retrospective Study Khanh Toan Nguyen, Thi Huong Pham, Van Lam Ngo, Thi Thuy My Nguyen, Thi Dao Nguyen, Van Thanh Le, Van Nhat Nguyen, Thi Thanh Thuy Nguyen, Khanh Ha Nguyen, Thi Nhung Ngo, Thi Hai Yen Le, Thi Phuong Thao Nguyen, Thi Ha Phuong Nguyen, Thi Hong Anh Vo, Thi Th Journal of Immunotherapy and Precision Oncology.2025; 8(4): 254. CrossRef
Clinical Impact of Genomic and Pathway Alterations in Stage I EGFR-Mutant Lung Adenocarcinoma Jae Seok Lee, Eun Kyung Kim, Kyung A Kim, Hyo Sup Shim Cancer Research and Treatment.2024; 56(1): 104. CrossRef
The Smokers Health Multiple ACtions (SMAC-1) Trial: Study Design and Results of the Baseline Round Alberto Antonicelli, Piergiorgio Muriana, Giovanni Favaro, Giuseppe Mangiameli, Ezio Lanza, Manuel Profili, Fabrizio Bianchi, Emanuela Fina, Giuseppe Ferrante, Simone Ghislandi, Daniela Pistillo, Giovanna Finocchiaro, Gianluigi Condorelli, Rosalba Lembo, Cancers.2024; 16(2): 417. CrossRef
Real-World Outcomes of Crizotinib in ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer Hyeon Hwa Kim, Jae Cheol Lee, In-Jae Oh, Eun Young Kim, Seong Hoon Yoon, Shin Yup Lee, Min Ki Lee, Jeong Eun Lee, Chan Kwon Park, Kye Young Lee, Sung Yong Lee, Seung Joon Kim, Jun Hyeok Lim, Chang-min Choi Cancers.2024; 16(3): 528. CrossRef
Lung Cancer Proteogenomics: Shaping the Future of Clinical Investigation Theofanis Vavilis, Maria Louiza Petre, Giannis Vatsellas, Alexandra Ainatzoglou, Eleni Stamoula, Athanasios Sachinidis, Malamatenia Lamprinou, Ioannis Dardalas, Ioannis N. Vamvakaris, Ioannis Gkiozos, Konstantinos N. Syrigos, Athanasios K. Anagnostopoulos Cancers.2024; 16(6): 1236. CrossRef
Survival analysis and gender differences in hypertrophic cardiomyopathy proband patients referred for genetic testing Rebeca Lorca, María Salgado, Rut Álvarez-Velasco, Julián R. Reguro, Vanesa Alonso, Juan Gómez, Eliecer Coto, Elías Cuesta-Llavona, Eva Lopez-Negrete, Isaac Pascual, Pablo Avanzas, Maite Tome International Journal of Cardiology.2024; 408: 132117. CrossRef
18F-Fluorodeoxyglucose Positron Emission Tomography-Based Risk Score Model for Prediction of Five-Year Survival Outcome after Curative Resection of Non-Small-Cell Lung Cancer Chae Hong Lim, Sang-Won Um, Hong Kwan Kim, Yong Soo Choi, Hong Ryul Pyo, Myung-Ju Ahn, Joon Young Choi Cancers.2024; 16(14): 2525. CrossRef
Study Progress of Circulating miRNA for Predicting Metastasis in Non-Small Cell Lung Cancer 靖靖 丛 Advances in Clinical Medicine.2024; 14(07): 65. CrossRef
Toll-like Receptors: Key Players in Squamous Cell Carcinoma Progression Jolanta Smok-Kalwat, Paulina Mertowska, Sebastian Mertowski, Stanisław Góźdź, Ewelina Grywalska Journal of Clinical Medicine.2024; 13(15): 4531. CrossRef
Timing of Palliative Care Consultation Impacts End of Life Care Outcomes in Metastatic Non-Small Cell Lung Cancer Cameron J. Oswalt, Morgan M. Nakatani, Jesse Troy, Steven Wolf, Susan C. Locke, Thomas W. LeBlanc Journal of Pain and Symptom Management.2024; 68(4): e325. CrossRef
Enhanced Lung Cancer Detection Using a Combined Ratio of Antigen–Autoantibody Immune Complexes against CYFRA 21-1 and p53 Heyjin Kim, Jin Kyung Lee, Hye-Ryoun Kim, Young Jun Hong Cancers.2024; 16(15): 2661. CrossRef
Discrimination of Lung Cancer and Benign Lung Diseases Using BALF Exosome DNA Methylation Profile Chinbayar Batochir, In Ae Kim, Eun Ji Jo, Eun-Bi Kim, Hee Joung Kim, Jae Young Hur, Do Won Kim, Hee Kyung Park, Kye Young Lee Cancers.2024; 16(15): 2765. CrossRef
The clinical significance of endoplasmic reticulum stress related genes in non-small cell lung cancer and analysis of single nucleotide polymorphism for CAV1 Shuang Li, Junting Chen, Baosen Zhou Frontiers in Molecular Biosciences.2024;[Epub] CrossRef
A Highly Sensitive Toluene Gas Sensor Based on Pd/PdO Decorated SnO2 Prepared by Electrospinning Chengyi Gong, Meng Chen, Fei Song, Peisi Yin, Xin Zhao, Xiaoyu You, Huaian Fu, Shanshan Yu, Xingyu Liu, Kai Zhang, Yongqi Yang, Zhipeng Tang, Xiangmin Du, Jiacong Xu, Qiang Jing, Bo Liu ACS Applied Electronic Materials.2024;[Epub] CrossRef
miR-137: a potential therapeutic target for lung cancer Shuanshuan Liu, Yanyun Ruan, Xu Chen, Bao He, Qi Chen Frontiers in Cell and Developmental Biology.2024;[Epub] CrossRef
Discovery of CLKs inhibitors for the treatment of non-small cell lung cancer Tianxing Hu, Jiali Huang, Rui Chen, Hui Zhang, Mai Liu, Renbing Wang, Wenyi Zhou, Dechun Huang, Mingkang Cao, Depeng Li, Zhiyu Li, Hongxi Wu, Jinlei Bian European Journal of Medicinal Chemistry.2024; 280: 116952. CrossRef
CASTOR1 phosphorylation predicts poor survival in male patients with KRAS-mutated lung adenocarcinoma Suet Kee Loo, Gabriel Sica, Xian Wang, Tingting Li, Luping Chen, Autumn Gaither-Davis, Yufei Huang, Timothy F. Burns, Laura P. Stabile, Shou-Jiang Gao Cell & Bioscience.2024;[Epub] CrossRef
Methylation modification is a poor prognostic factor in non-small cell lung Cancer and regulates the tumor microenvironment: mRNA molecular structure and function Kai Yang, YuPing Yang, Lin Yu, Fan Yang, YuXin Xiang, Jun Zeng, Na Huang International Journal of Biological Macromolecules.2024; 282: 137214. CrossRef
Impact of Postoperative Prolonged Air Leakage on Long-Term Pulmonary Function after Lobectomy for Lung Cancer June Yeop Lee, Joonseok Lee, Varissara Javakijkarnjanakul, Beatrice Chia-Sui Shih, Woohyun Jung, Jae Hyun Jeon, Kwhanmien Kim, Sanghoon Jheon, Sukki Cho Journal of Chest Surgery.2024; 57(6): 511. CrossRef
M1 macrophage-related prognostic model by combining bulk and single-cell transcriptomic data in NSCLC Liu Zhe, Liu Fang, Petinrin Olutomilayo Olayemi, Toseef Muhammad, Chen Nanjun, Zhu Zhongxu, Wong Ka-Chun Exploration of Medicine.2024;[Epub] CrossRef
Detection of aberrant locomotor activity in a mouse model of lung cancer via home cage monitoring Michele Tomanelli, Federica Guffanti, Giulia Vargiu, Edoardo Micotti, Mara Rigamonti, Francesca Tumiatti, Elisa Caiola, Mirko Marabese, Massimo Broggini Frontiers in Oncology.2024;[Epub] CrossRef
Combinatorial Blood Platelets-Derived circRNA and mRNA Signature for Early-Stage Lung Cancer Detection Silvia D’Ambrosi, Stavros Giannoukakos, Mafalda Antunes-Ferreira, Carlos Pedraz-Valdunciel, Jillian W. P. Bracht, Nicolas Potie, Ana Gimenez-Capitan, Michael Hackenberg, Alberto Fernandez Hilario, Miguel A. Molina-Vila, Rafael Rosell, Thomas Würdinger, Da International Journal of Molecular Sciences.2023; 24(5): 4881. CrossRef
Low diffusion capacity predicts poor prognosis in extensive stage small cell lung cancer: a single-center analysis of 10 years Jee Seon Kim, Eun Ji Kim, Jong Geol Jang, Kyung Soo Hong, June Hong Ahn Journal of Cancer Research and Clinical Oncology.2023; 149(10): 7275. CrossRef
Prior treated tuberculosis and mortality risk in lung cancer Kuang-Ming Liao, Chung-Shu Lee, Yu-Cih Wu, Chin-Chung Shu, Chung-Han Ho Frontiers in Medicine.2023;[Epub] CrossRef
All-round counterattack to conquer lung cancer Seung Hun Jang Journal of the Korean Medical Association.2023; 66(3): 154. CrossRef
Metabolic profiles of lung adenocarcinoma via peripheral blood and diagnostic model construction Kyung Soo Kim, Seok Whan Moon, Mi Hyung Moon, Kwan Yong Hyun, Seung Joon Kim, Young Koon Kim, Kwang Youl Kim, Dong Wook Jekarl, Eun-Jee Oh, Yonggoo Kim Scientific Reports.2023;[Epub] CrossRef
STEMI in women. Life expectancy recovery after primary percutaneous coronary intervention Marcel Almendárez, Rut Álvarez-Velasco, Pablo Avanzas, Alberto Alperi, Luis Gutiérrez, David Ledesma, Javier Martínez, Daniel Hernández-Vaquero, Rebeca Lorca, Luis Arboine, Cesar Morís, Isaac Pascual Revista Española de Cardiología (English Edition).2023; 76(12): 1003. CrossRef
A Retrospective Analysis Comparing VATS Cost Discrepancies and Outcomes in Primary Lung Cancer vs. Second Primary Lung Cancer Patients Bogdan Cosmin Tanase, Alin Ionut Burlacu, Claudiu Eduard Nistor, Teodor Horvat, Cristian Oancea, Monica Marc, Emanuela Tudorache, Tudor Mateescu, Diana Manolescu Healthcare.2023; 11(12): 1745. CrossRef
IAMCEST en mujeres. Recuperación de la expectativa de vida tras la intervención coronaria percutánea Marcel Almendárez, Rut Álvarez-Velasco, Pablo Avanzas, Alberto Alperi, Luis Gutiérrez, David Ledesma, Javier Martínez, Daniel Hernández-Vaquero, Rebeca Lorca, Luis Arboine, Cesar Morís, Isaac Pascual Revista Española de Cardiología.2023; 76(12): 1003. CrossRef
Synthetic Tabular Data Based on Generative Adversarial Networks in Health Care: Generation and Validation Using the Divide-and-Conquer Strategy Ha Ye Jin Kang, Erdenebileg Batbaatar, Dong-Woo Choi, Kui Son Choi, Minsam Ko, Kwang Sun Ryu JMIR Medical Informatics.2023; 11: e47859. CrossRef
Exosomes in lung cancer metastasis, diagnosis, and immunologically relevant advances Jianhua Zhao, Xiwen Li, Lele Liu, Zhen Zhu, Chunyan He Frontiers in Immunology.2023;[Epub] CrossRef